Folate Binding Protein / FBP Antibody

About the Target

FR-ALPHA is a target of interest in many antibody-based workflows. Folate binding protein (FBP), also known as folate receptor (FR), is a high-affinity glycoprotein that binds folic acid and its analogues and exists in both membrane-bound and soluble forms. It is primarily expressed in limited normal tissues such as kidney proximal tubules, placenta, and intestinal mucosa, but is significantly overexpressed in many epithelial cancers including ovarian, endometrial, breast, and lung cancers. Depending on the literature source, FR-ALPHA may also be discussed as Folate Binding Protein / FBP and Folate receptor alpha.

Reported cellular context includes cell membrane, cytoplasmic vesicle, endosome, and membrane, which can matter when signal is compared across treatments or changing cell states. Following FR-ALPHA across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

FR-ALPHA is commonly interpreted in the context of cancer and immunology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cytoplasmic vesicle, and endosome, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell membrane, cytoplasmic vesicle, and endosome across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• context differences tied to immune-cell state, activation, or lineage composition
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for FR-ALPHA. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in FR-ALPHA reflect biology rather than handling. When interpreting FR-ALPHA, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep FR-ALPHA trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.